About Sri Sai Chandana API
Sri Sai Chandana API is a company based in Visakhapatnam (India). The company has 13 employees. Sri Sai Chandana API offers products and services including Active Pharmaceutical Ingredients and CDMO Services.
- Headquarter Visakhapatnam, India
- Employees 13
- SectorsHealthcare
- Email••••••••
- Legal Name Sri Sai Chandana Api Pvt Ltd
- Date of Incorporation 23 Mar, 2015
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
- Annual Revenue₹108 Cr
FY 2025 · +33% YoY
- Net Profit₹77.5 Lakh
FY 2025 · 1% margin
- EBITDA₹5.88 Cr
FY 2025 · 5% margin
- Employee Count13
Associated legal entities of Sri Sai Chandana API
Sri Sai Chandana API operates through Srisaichandana Api Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srisaichandana Api Private Limited CIN U24232AP2015PTC096364 | Active | 23 Mar 2015 | Visakhapatnam, Andhra Pradesh | ₹108 Cr | 13 | 2 | View details |
Products & Services of Sri Sai Chandana API
Sri Sai Chandana API offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and CDMO Services.
Active Pharmaceutical Ingredients are manufactured with adherence to high-quality standards to ensure safety and efficacy in healthcare applications
CDMO services are offered for API research, development, and production to support tailored solutions from concept to market
Board of directors of Srisaichandana Api Private Limited (Sri Sai Chandana API)
Srisaichandana Api Private Limited is the primary company behind Sri Sai Chandana API. The board of Srisaichandana Api Private Limited currently have 2 directors; the longest-serving is Anjaneya Pattabhi Rameswara Rao Chandana, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anjaneya Pattabhi Rameswara Rao Chandana DIN 00105304 | Director | 23 Mar 2015 | 11 yrs 6 mo | Srisaichandana Api Private Limited |
| Uddagiri Tata Rao DIN 00097229 | Director | 23 Mar 2015 | 11 yrs 6 mo | Srisaichandana Api Private Limited |
Financials of Sri Sai Chandana API
Figures of Srisaichandana Api Private Limited, the primary company behind Sri Sai Chandana API, for FY 2025. Revenue was ₹108 Cr (+33% year on year). Net profit was ₹77.5 Lakh (1% margin). EBITDA was ₹5.88 Cr (5% margin). Revenue has grown at a compounded annual rate of +7% over three years and +20% over five years.
- ₹108 CrRevenue · FY 2025 · +33% YoY
- ₹77.5 LakhNet profit · 1% margin
- ₹5.88 CrEBITDA · 5% margin
- ₹7.00 CrPaid-up capital
- 13Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Srisaichandana Api Private Limited are on its company page.
Detailed financial statements for Sri Sai Chandana API
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sri Sai Chandana API
10 companies that operate in the same segment as Sri Sai Chandana API (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sri Sai Chandana API
Sri Sai Chandana API is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
Sri Sai Chandana API has 13 employees.
The primary company behind Sri Sai Chandana API, Srisaichandana Api Private Limited, reported revenue of ₹108 Cr for FY 2025, up 33% year on year.
Sri Sai Chandana API is identified as a leading active pharmaceutical company that advances global well-being through the development of cutting-edge solutions. High-quality pharmaceutical products are delivered to address evolving patient needs, with a strong emphasis on quality, innovation, integrity, and sustainability in operations. Precision formulations and specialized therapeutics are created using rigorous processes, ensuring efficacy and safety. Partnerships with healthcare experts are fostered to contribute to medical advancements, while environmental responsibility is integrated into business practices to promote positive impacts on communities and the world.
Sri Sai Chandana API offers Active Pharmaceutical Ingredients and CDMO Services.
Sri Sai Chandana API operates through Srisaichandana Api Private Limited.
The legal entities of Sri Sai Chandana API currently have 2 directors, including Anjaneya Pattabhi Rameswara Rao Chandana, Uddagiri Tata Rao.